George Clinical has expertise in disorders that affect the brain, such as stroke, epilepsy, dementia, and sleep apnoea. George Clinical’s neurological investigator networks have been cultivated over many years by participating in some of the world’s largest clinical neurology research trials, one of which is the largest ever study in acute ischemic stroke.

Stroke is a second leading cause of death worldwide and expected to worsen as society ages. In Asia, the change in lifestyle and diet has seen a marked increase in the prevalence of stroke, particularly in ischaemic stroke.

George Clinical has supported the work of The George Institute for Global Health to reduce the worldwide burden of neurological diseases by implementing a number of high impact clinical trials and establishing a network of over 200 sites and recruiting over 10,000 patients from around the world. The George Clinical neurological investigator network is particularly strong in the Asia Pacific, with centres deep within North Asia where ischemic stroke is most prevalent.

George Clinical engage with scientific leadership that are regularly called upon to develop new strategies for global decision makers on how neurological medicine is practiced.

George Clinical’s therapeutic expertise spread throughout 27 countries and 162 sites.

Our clinical trial services in neurological health include: